世界の胃腸用OTC医薬品市場2023年-2027年

◆英語タイトル:Global Gastrointestinal OTC Drugs Market 2023-2027

Technavioが発行した調査報告書(IRTNTR75270-23)◆商品コード:IRTNTR75270-23
◆発行会社(リサーチ会社):Technavio
◆発行日:2023年5月4日
◆ページ数:約120
◆レポート形式:英語 / PDF
◆納品方法:Eメール(受注後24時間以内)
◆調査対象地域:北米、ヨーロッパ、アジア、その他地域
◆産業分野:医薬品
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD2,500 ⇒換算¥380,000見積依頼/購入/質問フォーム
Enterprise License(同一法人内共有可)USD4,000 ⇒換算¥608,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行・送付致します。(請求書発行日より2ヶ月以内の銀行振込条件、カード払いに変更可)
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。

❖ レポートの概要 ❖

Technavio社の市場調査では、世界の胃腸用OTC医薬品市場規模が、2022年から2027年の間に4,759.86百万ドルへ達し、予測期間中に年平均5.29%成長する見通しです。当書では、胃腸用OTC医薬品の世界市場について調査し、エグゼクティブサマリー、市場状況、市場規模・予測、過去の市場規模、ファイブフォース分析、製品別(制酸剤、下剤、下痢止め剤、鎮吐剤、その他)分析、流通チャネル別(オフライン、オンライン)分析、顧客状況、地域別(北米、ヨーロッパ、アジア、その他地域、アメリカ、中国、日本、ドイツ、フランス)分析、成長要因・課題・動向、企業状況、企業分析など、以下の構成でお届けします。また、当書で記載されている企業情報には、Abbott Laboratories、AbbVie Inc.、Bausch Health Co. Inc.、Bayer AG、Cipla Ltd.、Dr Reddys Laboratories Ltd.、Eisai Co. Ltd.、GlaxoSmithKline Plc、Haleon Plc、Johnson and Johnson Services Inc.、Merck KGaA、Novartis AG、Pfizer Inc.などが含まれています。
・エグゼクティブサマリー
・市場状況
・市場規模・予測
・過去の市場規模
・ファイブフォース分析
・世界の胃腸用OTC医薬品市場規模:製品別
- 制酸剤の市場規模
- 下剤の市場規模
- 下痢止め剤の市場規模
- 鎮吐剤の市場規模
- その他胃腸用OTC医薬品の市場規模
・世界の胃腸用OTC医薬品市場規模:流通チャネル別
- オフラインの市場規模
- オンラインチャネルの市場規模
・顧客状況
・世界の胃腸用OTC医薬品市場規模:地域別
- 北米の胃腸用OTC医薬品市場規模
- ヨーロッパの胃腸用OTC医薬品市場規模
- アジアの胃腸用OTC医薬品市場規模
- その他地域の胃腸用OTC医薬品市場規模
- アメリカの胃腸用OTC医薬品市場規模
- 中国の胃腸用OTC医薬品市場規模
- 日本の胃腸用OTC医薬品市場規模
- ドイツの胃腸用OTC医薬品市場規模
- フランスの胃腸用OTC医薬品市場規模
・成長要因・課題・動向
・企業状況
・企業分析

Technavio社は、利益、価格、競争、プロモーションなどの主要なパラメーターの分析により、複数のソースからのデータを調査、統合、および総括することにより、胃腸用OTC医薬品市場の詳細な全体像を提供します。主要産業のインフルエンサーを特定することにより、市場の様々な側面を提示します。提示されたデータは包括的​​で信頼性が高く、一次および二次の広範な調査の結果です。 Technavio社の市場調査書は、正確な胃腸用OTC医薬品市場の成長を予測するための定性的および定量的調査を使用し、完全な競争状況と詳細なベンダー選択方法と分析を提供します。

胃腸用OTC医薬品の世界市場 2023-2027

胃腸用OTC医薬品市場は、2022年から2027年にかけて4,759.86百万米ドルの成長が予測され、予測期間中のCAGRは5.29%で加速すると予測されます。
当レポートでは、胃腸用OTC医薬品市場の全体的な分析、市場規模と予測、動向、成長促進要因、課題に加え、約25のベンダーを網羅したベンダー分析も提供しています。

現在の市場シナリオ、最新動向と促進要因、市場環境全体に関する最新分析を提供しています。市場は、胃腸疾患の有病率の増加、入手が容易で手ごろな価格であることによる胃腸OTC医薬品の採用の増加、複数の支払いオプションの利用が可能であることなどが原動力となっています。

Technavioの胃腸OTC医薬品市場は以下のように区分されています:

・製品別:
– 制酸剤
– 制酸剤
– 下痢止め
– 制吐剤
– その他

・流通チャネル別:
– オフライン
– オンライン

・地域別:
– 北米
– ヨーロッパ
– アジア
– その他の地域(ROW)

本調査では、今後数年間の胃腸用OTC医薬品市場の成長を促進する主な要因の1つとして、胃腸用OTC医薬品のオンラインプラットフォーム導入の増加を挙げています。また、医薬品承認数の増加や、製薬会社による処方薬から胃腸用OTC医薬品へのシフトも、市場の大きな需要につながるでしょう。

本レポートでは、胃腸OTC医薬品市場について以下の分野をカバーしています:
– 胃腸OTC医薬品市場のサイジング
– 胃腸OTC医薬品市場の予測
– 胃腸OTC医薬品市場の産業分析

強固なベンダー分析は、クライアントが市場でのポジションを向上できるように設計されており、これに沿って本レポートには、Abbott Laboratories, AbbVie Inc., Bausch Health Co. Inc., Bayer AG, Cipla Ltd., Dr Reddys Laboratories Ltd., Eisai Co. Ltd., GlaxoSmithKline Plc, Haleon Plc, Johnson and Johnson Services Inc., Merck KGaA, Novartis AG, Pfizer Inc., Phathom Pharmaceuticals Inc., Prestige Consumer Healthcare Inc., Sanofi SA, SonoScape Medical Corp., Sun Pharmaceutical Industries Ltd., Takeda Pharmaceutical Co. Ltd., Vee Excel Drugs And Pharmaceuticals Pvt. Ltd., Zoic Pharmaceuticals Pvt. Ltd., and Boehringer Ingelheim International GmbHなどの企業情報が含まれています。また、消化器系OTC医薬品市場の分析レポートには、市場成長に影響を与える今後の動向や課題に関する情報も含まれています。これは、企業が今後の成長機会を戦略的に活用するのに役立つものです。

本調査は、業界の主要参加者からのインプットを含め、一次情報と二次情報を客観的に組み合わせて実施しました。当レポートでは、主要ベンダーの分析に加え、包括的な市場とベンダーの状況を掲載しています。

利益、価格、競争、プロモーションなどの主要パラメータの分析により、複数の情報源からのデータを調査、統合、総括することで、市場の詳細な姿を示しています。また、主要な業界インフルエンサーを特定することで、市場の様々な側面を提示しています。提示されるデータは包括的で信頼性が高く、一次および二次にわたる広範な調査の結果です。市場調査レポートは、正確な市場成長を予測するために、完全な競争環境と、質的・量的調査を用いた綿密なベンダー選定方法と分析を提供します。

❖ レポートの目次 ❖

• 1 Executive Summary
o 1.1 Market overview
o Exhibit 01: Executive Summary – Chart on Market Overview
o Exhibit 02: Executive Summary – Data Table on Market Overview
o Exhibit 03: Executive Summary – Chart on Global Market Characteristics
o Exhibit 04: Executive Summary – Chart on Market By Geographical Landscape
o Exhibit 05: Executive Summary – Chart on Market Segmentation by Product
o Exhibit 06: Executive Summary – Chart on Market Segmentation by Distribution Channel
o Exhibit 07: Executive Summary – Chart on Incremental Growth
o Exhibit 08: Executive Summary – Data Table on Incremental Growth
o Exhibit 09: Executive Summary – Chart on Vendor Market Positioning
• 2 Market Landscape
o 2.1 Market ecosystem
o Exhibit 10: Parent market
o Exhibit 11: Market Characteristics
• 3 Market Sizing
o 3.1 Market definition
o Exhibit 12: Offerings of vendors included in the market definition
o 3.2 Market segment analysis
o Exhibit 13: Market segments
o 3.3 Market size 2022
o 3.4 Market outlook: Forecast for 2022-2027
o Exhibit 14: Chart on Global – Market size and forecast 2022-2027 ($ million)
o Exhibit 15: Data Table on Global – Market size and forecast 2022-2027 ($ million)
o Exhibit 16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
o Exhibit 17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)
• 4 Historic Market Size
o 4.1 Global gastrointestinal OTC drugs market 2017 – 2021
o Exhibit 18: Historic Market Size – Data Table on global gastrointestinal otc drugs market 2017 – 2021 ($ million)
o 4.2 Product Segment Analysis 2017 – 2021
o Exhibit 19: Historic Market Size – Product Segment 2017 – 2021 ($ million)
o 4.3 Distribution Channel Segment Analysis 2017 – 2021
o Exhibit 20: Historic Market Size – Distribution Channel Segment 2017 – 2021 ($ million)
o 4.4 Geography Segment Analysis 2017 – 2021
o Exhibit 21: Historic Market Size – Geography Segment 2017 – 2021 ($ million)
o 4.5 Country Segment Analysis 2017 – 2021
o Exhibit 22: Historic Market Size – Country Segment 2017 – 2021 ($ million)
• 5 Five Forces Analysis
o 5.1 Five forces summary
o Exhibit 23: Five forces analysis – Comparison between 2022 and 2027
o 5.2 Bargaining power of buyers
o Exhibit 24: Chart on Bargaining power of buyers – Impact of key factors 2022 and 2027
o 5.3 Bargaining power of suppliers
o Exhibit 25: Bargaining power of suppliers – Impact of key factors in 2022 and 2027
o 5.4 Threat of new entrants
o Exhibit 26: Threat of new entrants – Impact of key factors in 2022 and 2027
o 5.5 Threat of substitutes
o Exhibit 27: Threat of substitutes – Impact of key factors in 2022 and 2027
o 5.6 Threat of rivalry
o Exhibit 28: Threat of rivalry – Impact of key factors in 2022 and 2027
o 5.7 Market condition
o Exhibit 29: Chart on Market condition – Five forces 2022 and 2027
• 6 Market Segmentation by Product
o 6.1 Market segments
o Exhibit 30: Chart on Product – Market share 2022-2027 (%)
o Exhibit 31: Data Table on Product – Market share 2022-2027 (%)
o 6.2 Comparison by Product
o Exhibit 32: Chart on Comparison by Product
o Exhibit 33: Data Table on Comparison by Product
o 6.3 Antacid – Market size and forecast 2022-2027
o Exhibit 34: Chart on Antacid – Market size and forecast 2022-2027 ($ million)
o Exhibit 35: Data Table on Antacid – Market size and forecast 2022-2027 ($ million)
o Exhibit 36: Chart on Antacid – Year-over-year growth 2022-2027 (%)
o Exhibit 37: Data Table on Antacid – Year-over-year growth 2022-2027 (%)
o 6.4 Laxatives – Market size and forecast 2022-2027
o Exhibit 38: Chart on Laxatives – Market size and forecast 2022-2027 ($ million)
o Exhibit 39: Data Table on Laxatives – Market size and forecast 2022-2027 ($ million)
o Exhibit 40: Chart on Laxatives – Year-over-year growth 2022-2027 (%)
o Exhibit 41: Data Table on Laxatives – Year-over-year growth 2022-2027 (%)
o 6.5 Anti-diarrheal – Market size and forecast 2022-2027
o Exhibit 42: Chart on Anti-diarrheal – Market size and forecast 2022-2027 ($ million)
o Exhibit 43: Data Table on Anti-diarrheal – Market size and forecast 2022-2027 ($ million)
o Exhibit 44: Chart on Anti-diarrheal – Year-over-year growth 2022-2027 (%)
o Exhibit 45: Data Table on Anti-diarrheal – Year-over-year growth 2022-2027 (%)
o 6.6 Anti-emetics – Market size and forecast 2022-2027
o Exhibit 46: Chart on Anti-emetics – Market size and forecast 2022-2027 ($ million)
o Exhibit 47: Data Table on Anti-emetics – Market size and forecast 2022-2027 ($ million)
o Exhibit 48: Chart on Anti-emetics – Year-over-year growth 2022-2027 (%)
o Exhibit 49: Data Table on Anti-emetics – Year-over-year growth 2022-2027 (%)
o 6.7 Others – Market size and forecast 2022-2027
o Exhibit 50: Chart on Others – Market size and forecast 2022-2027 ($ million)
o Exhibit 51: Data Table on Others – Market size and forecast 2022-2027 ($ million)
o Exhibit 52: Chart on Others – Year-over-year growth 2022-2027 (%)
o Exhibit 53: Data Table on Others – Year-over-year growth 2022-2027 (%)
o 6.8 Market opportunity by Product
o Exhibit 54: Market opportunity by Product ($ million)
o Exhibit 55: Data Table on Market opportunity by Product ($ million)
• 7 Market Segmentation by Distribution Channel
o 7.1 Market segments
o Exhibit 56: Chart on Distribution Channel – Market share 2022-2027 (%)
o Exhibit 57: Data Table on Distribution Channel – Market share 2022-2027 (%)
o 7.2 Comparison by Distribution Channel
o Exhibit 58: Chart on Comparison by Distribution Channel
o Exhibit 59: Data Table on Comparison by Distribution Channel
o 7.3 Offline – Market size and forecast 2022-2027
o Exhibit 60: Chart on Offline – Market size and forecast 2022-2027 ($ million)
o Exhibit 61: Data Table on Offline – Market size and forecast 2022-2027 ($ million)
o Exhibit 62: Chart on Offline – Year-over-year growth 2022-2027 (%)
o Exhibit 63: Data Table on Offline – Year-over-year growth 2022-2027 (%)
o 7.4 Online – Market size and forecast 2022-2027
o Exhibit 64: Chart on Online – Market size and forecast 2022-2027 ($ million)
o Exhibit 65: Data Table on Online – Market size and forecast 2022-2027 ($ million)
o Exhibit 66: Chart on Online – Year-over-year growth 2022-2027 (%)
o Exhibit 67: Data Table on Online – Year-over-year growth 2022-2027 (%)
o 7.5 Market opportunity by Distribution Channel
o Exhibit 68: Market opportunity by Distribution Channel ($ million)
o Exhibit 69: Data Table on Market opportunity by Distribution Channel ($ million)
• 8 Customer Landscape
o 8.1 Customer landscape overview
o Exhibit 70: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
• 9 Geographic Landscape
o 9.1 Geographic segmentation
o Exhibit 71: Chart on Market share By Geographical Landscape 2022-2027 (%)
o Exhibit 72: Data Table on Market share By Geographical Landscape 2022-2027 (%)
o 9.2 Geographic comparison
o Exhibit 73: Chart on Geographic comparison
o Exhibit 74: Data Table on Geographic comparison
o 9.3 North America – Market size and forecast 2022-2027
o Exhibit 75: Chart on North America – Market size and forecast 2022-2027 ($ million)
o Exhibit 76: Data Table on North America – Market size and forecast 2022-2027 ($ million)
o Exhibit 77: Chart on North America – Year-over-year growth 2022-2027 (%)
o Exhibit 78: Data Table on North America – Year-over-year growth 2022-2027 (%)
o 9.4 Europe – Market size and forecast 2022-2027
o Exhibit 79: Chart on Europe – Market size and forecast 2022-2027 ($ million)
o Exhibit 80: Data Table on Europe – Market size and forecast 2022-2027 ($ million)
o Exhibit 81: Chart on Europe – Year-over-year growth 2022-2027 (%)
o Exhibit 82: Data Table on Europe – Year-over-year growth 2022-2027 (%)
o 9.5 Asia – Market size and forecast 2022-2027
o Exhibit 83: Chart on Asia – Market size and forecast 2022-2027 ($ million)
o Exhibit 84: Data Table on Asia – Market size and forecast 2022-2027 ($ million)
o Exhibit 85: Chart on Asia – Year-over-year growth 2022-2027 (%)
o Exhibit 86: Data Table on Asia – Year-over-year growth 2022-2027 (%)
o 9.6 Rest of World (ROW) – Market size and forecast 2022-2027
o Exhibit 87: Chart on Rest of World (ROW) – Market size and forecast 2022-2027 ($ million)
o Exhibit 88: Data Table on Rest of World (ROW) – Market size and forecast 2022-2027 ($ million)
o Exhibit 89: Chart on Rest of World (ROW) – Year-over-year growth 2022-2027 (%)
o Exhibit 90: Data Table on Rest of World (ROW) – Year-over-year growth 2022-2027 (%)
o 9.7 US – Market size and forecast 2022-2027
o Exhibit 91: Chart on US – Market size and forecast 2022-2027 ($ million)
o Exhibit 92: Data Table on US – Market size and forecast 2022-2027 ($ million)
o Exhibit 93: Chart on US – Year-over-year growth 2022-2027 (%)
o Exhibit 94: Data Table on US – Year-over-year growth 2022-2027 (%)
o 9.8 China – Market size and forecast 2022-2027
o Exhibit 95: Chart on China – Market size and forecast 2022-2027 ($ million)
o Exhibit 96: Data Table on China – Market size and forecast 2022-2027 ($ million)
o Exhibit 97: Chart on China – Year-over-year growth 2022-2027 (%)
o Exhibit 98: Data Table on China – Year-over-year growth 2022-2027 (%)
o 9.9 Japan – Market size and forecast 2022-2027
o Exhibit 99: Chart on Japan – Market size and forecast 2022-2027 ($ million)
o Exhibit 100: Data Table on Japan – Market size and forecast 2022-2027 ($ million)
o Exhibit 101: Chart on Japan – Year-over-year growth 2022-2027 (%)
o Exhibit 102: Data Table on Japan – Year-over-year growth 2022-2027 (%)
o 9.10 Germany – Market size and forecast 2022-2027
o Exhibit 103: Chart on Germany – Market size and forecast 2022-2027 ($ million)
o Exhibit 104: Data Table on Germany – Market size and forecast 2022-2027 ($ million)
o Exhibit 105: Chart on Germany – Year-over-year growth 2022-2027 (%)
o Exhibit 106: Data Table on Germany – Year-over-year growth 2022-2027 (%)
o 9.11 France – Market size and forecast 2022-2027
o Exhibit 107: Chart on France – Market size and forecast 2022-2027 ($ million)
o Exhibit 108: Data Table on France – Market size and forecast 2022-2027 ($ million)
o Exhibit 109: Chart on France – Year-over-year growth 2022-2027 (%)
o Exhibit 110: Data Table on France – Year-over-year growth 2022-2027 (%)
o 9.12 Market opportunity By Geographical Landscape
o Exhibit 111: Market opportunity By Geographical Landscape ($ million)
o Exhibit 112: Data Tables on Market opportunity By Geographical Landscape ($ million)
• 10 Drivers, Challenges, and Trends
o 10.1 Market drivers
o 10.2 Market challenges
o 10.3 Impact of drivers and challenges
o Exhibit 113: Impact of drivers and challenges in 2022 and 2027
o 10.4 Market trends
• 11 Vendor Landscape
o 11.1 Overview
o 11.2 Vendor landscape
o Exhibit 114: Overview on Criticality of inputs and Factors of differentiation
o 11.3 Landscape disruption
o Exhibit 115: Overview on factors of disruption
o 11.4 Industry risks
o Exhibit 116: Impact of key risks on business
• 12 Vendor Analysis
o 12.1 Vendors covered
o Exhibit 117: Vendors covered
o 12.2 Market positioning of vendors
o Exhibit 118: Matrix on vendor position and classification
o 12.3 Abbott Laboratories
o Exhibit 119: Abbott Laboratories – Overview
o Exhibit 120: Abbott Laboratories – Business segments
o Exhibit 121: Abbott Laboratories – Key news
o Exhibit 122: Abbott Laboratories – Key offerings
o Exhibit 123: Abbott Laboratories – Segment focus
o 12.4 AbbVie Inc.
o Exhibit 124: AbbVie Inc. – Overview
o Exhibit 125: AbbVie Inc. – Product / Service
o Exhibit 126: AbbVie Inc. – Key news
o Exhibit 127: AbbVie Inc. – Key offerings
o 12.5 Bausch Health Co. Inc.
o Exhibit 128: Bausch Health Co. Inc. – Overview
o Exhibit 129: Bausch Health Co. Inc. – Business segments
o Exhibit 130: Bausch Health Co. Inc. – Key news
o Exhibit 131: Bausch Health Co. Inc. – Key offerings
o Exhibit 132: Bausch Health Co. Inc. – Segment focus
o 12.6 Bayer AG
o Exhibit 133: Bayer AG – Overview
o Exhibit 134: Bayer AG – Business segments
o Exhibit 135: Bayer AG – Key news
o Exhibit 136: Bayer AG – Key offerings
o Exhibit 137: Bayer AG – Segment focus
o 12.7 Boehringer Ingelheim International GmbH
o Exhibit 138: Boehringer Ingelheim International GmbH – Overview
o Exhibit 139: Boehringer Ingelheim International GmbH – Business segments
o Exhibit 140: Boehringer Ingelheim International GmbH – Key news
o Exhibit 141: Boehringer Ingelheim International GmbH – Key offerings
o Exhibit 142: Boehringer Ingelheim International GmbH – Segment focus
o 12.8 Cipla Ltd.
o Exhibit 143: Cipla Ltd. – Overview
o Exhibit 144: Cipla Ltd. – Business segments
o Exhibit 145: Cipla Ltd. – Key news
o Exhibit 146: Cipla Ltd. – Key offerings
o Exhibit 147: Cipla Ltd. – Segment focus
o 12.9 Dr Reddys Laboratories Ltd.
o Exhibit 148: Dr Reddys Laboratories Ltd. – Overview
o Exhibit 149: Dr Reddys Laboratories Ltd. – Business segments
o Exhibit 150: Dr Reddys Laboratories Ltd. – Key offerings
o Exhibit 151: Dr Reddys Laboratories Ltd. – Segment focus
o 12.10 GlaxoSmithKline Plc
o Exhibit 152: GlaxoSmithKline Plc – Overview
o Exhibit 153: GlaxoSmithKline Plc – Business segments
o Exhibit 154: GlaxoSmithKline Plc – Key news
o Exhibit 155: GlaxoSmithKline Plc – Key offerings
o Exhibit 156: GlaxoSmithKline Plc – Segment focus
o 12.11 Haleon Plc
o Exhibit 157: Haleon Plc – Overview
o Exhibit 158: Haleon Plc – Business segments
o Exhibit 159: Haleon Plc – Key offerings
o Exhibit 160: Haleon Plc – Segment focus
o 12.12 Johnson and Johnson Services Inc.
o Exhibit 161: Johnson and Johnson Services Inc. – Overview
o Exhibit 162: Johnson and Johnson Services Inc. – Business segments
o Exhibit 163: Johnson and Johnson Services Inc. – Key news
o Exhibit 164: Johnson and Johnson Services Inc. – Key offerings
o Exhibit 165: Johnson and Johnson Services Inc. – Segment focus
o 12.13 Novartis AG
o Exhibit 166: Novartis AG – Overview
o Exhibit 167: Novartis AG – Business segments
o Exhibit 168: Novartis AG – Key offerings
o Exhibit 169: Novartis AG – Segment focus
o 12.14 Pfizer Inc.
o Exhibit 170: Pfizer Inc. – Overview
o Exhibit 171: Pfizer Inc. – Product / Service
o Exhibit 172: Pfizer Inc. – Key news
o Exhibit 173: Pfizer Inc. – Key offerings
o 12.15 Prestige Consumer Healthcare Inc.
o Exhibit 174: Prestige Consumer Healthcare Inc. – Overview
o Exhibit 175: Prestige Consumer Healthcare Inc. – Business segments
o Exhibit 176: Prestige Consumer Healthcare Inc. – Key offerings
o Exhibit 177: Prestige Consumer Healthcare Inc. – Segment focus
o 12.16 Sanofi SA
o Exhibit 178: Sanofi SA – Overview
o Exhibit 179: Sanofi SA – Business segments
o Exhibit 180: Sanofi SA – Key news
o Exhibit 181: Sanofi SA – Key offerings
o Exhibit 182: Sanofi SA – Segment focus
o 12.17 Takeda Pharmaceutical Co. Ltd.
o Exhibit 183: Takeda Pharmaceutical Co. Ltd. – Overview
o Exhibit 184: Takeda Pharmaceutical Co. Ltd. – Product / Service
o Exhibit 185: Takeda Pharmaceutical Co. Ltd. – Key news
o Exhibit 186: Takeda Pharmaceutical Co. Ltd. – Key offerings
• 13 Appendix
o 13.1 Scope of the report
o 13.2 Inclusions and exclusions checklist
o Exhibit 187: Inclusions checklist
o Exhibit 188: Exclusions checklist
o 13.3 Currency conversion rates for US$
o Exhibit 189: Currency conversion rates for US$
o 13.4 Research methodology
o Exhibit 190: Research methodology
o Exhibit 191: Validation techniques employed for market sizing
o Exhibit 192: Information sources
o 13.5 List of abbreviations
o Exhibit 193: List of abbreviations

Exhibits:
Exhibits1: Executive Summary – Chart on Market Overview
Exhibits2: Executive Summary – Data Table on Market Overview
Exhibits3: Executive Summary – Chart on Global Market Characteristics
Exhibits4: Executive Summary – Chart on Market By Geographical Landscape
Exhibits5: Executive Summary – Chart on Market Segmentation by Product
Exhibits6: Executive Summary – Chart on Market Segmentation by Distribution Channel
Exhibits7: Executive Summary – Chart on Incremental Growth
Exhibits8: Executive Summary – Data Table on Incremental Growth
Exhibits9: Executive Summary – Chart on Vendor Market Positioning
Exhibits10: Parent market
Exhibits11: Market Characteristics
Exhibits12: Offerings of vendors included in the market definition
Exhibits13: Market segments
Exhibits14: Chart on Global – Market size and forecast 2022-2027 ($ million)
Exhibits15: Data Table on Global – Market size and forecast 2022-2027 ($ million)
Exhibits16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
Exhibits17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)
Exhibits18: Historic Market Size – Data Table on global gastrointestinal otc drugs market 2017 – 2021 ($ million)
Exhibits19: Historic Market Size – Product Segment 2017 – 2021 ($ million)
Exhibits20: Historic Market Size – Distribution Channel Segment 2017 – 2021 ($ million)
Exhibits21: Historic Market Size – Geography Segment 2017 – 2021 ($ million)
Exhibits22: Historic Market Size – Country Segment 2017 – 2021 ($ million)
Exhibits23: Five forces analysis – Comparison between 2022 and 2027
Exhibits24: Chart on Bargaining power of buyers – Impact of key factors 2022 and 2027
Exhibits25: Bargaining power of suppliers – Impact of key factors in 2022 and 2027
Exhibits26: Threat of new entrants – Impact of key factors in 2022 and 2027
Exhibits27: Threat of substitutes – Impact of key factors in 2022 and 2027
Exhibits28: Threat of rivalry – Impact of key factors in 2022 and 2027
Exhibits29: Chart on Market condition – Five forces 2022 and 2027
Exhibits30: Chart on Product – Market share 2022-2027 (%)
Exhibits31: Data Table on Product – Market share 2022-2027 (%)
Exhibits32: Chart on Comparison by Product
Exhibits33: Data Table on Comparison by Product
Exhibits34: Chart on Antacid – Market size and forecast 2022-2027 ($ million)
Exhibits35: Data Table on Antacid – Market size and forecast 2022-2027 ($ million)
Exhibits36: Chart on Antacid – Year-over-year growth 2022-2027 (%)
Exhibits37: Data Table on Antacid – Year-over-year growth 2022-2027 (%)
Exhibits38: Chart on Laxatives – Market size and forecast 2022-2027 ($ million)
Exhibits39: Data Table on Laxatives – Market size and forecast 2022-2027 ($ million)
Exhibits40: Chart on Laxatives – Year-over-year growth 2022-2027 (%)
Exhibits41: Data Table on Laxatives – Year-over-year growth 2022-2027 (%)
Exhibits42: Chart on Anti-diarrheal – Market size and forecast 2022-2027 ($ million)
Exhibits43: Data Table on Anti-diarrheal – Market size and forecast 2022-2027 ($ million)
Exhibits44: Chart on Anti-diarrheal – Year-over-year growth 2022-2027 (%)
Exhibits45: Data Table on Anti-diarrheal – Year-over-year growth 2022-2027 (%)
Exhibits46: Chart on Anti-emetics – Market size and forecast 2022-2027 ($ million)
Exhibits47: Data Table on Anti-emetics – Market size and forecast 2022-2027 ($ million)
Exhibits48: Chart on Anti-emetics – Year-over-year growth 2022-2027 (%)
Exhibits49: Data Table on Anti-emetics – Year-over-year growth 2022-2027 (%)
Exhibits50: Chart on Others – Market size and forecast 2022-2027 ($ million)
Exhibits51: Data Table on Others – Market size and forecast 2022-2027 ($ million)
Exhibits52: Chart on Others – Year-over-year growth 2022-2027 (%)
Exhibits53: Data Table on Others – Year-over-year growth 2022-2027 (%)
Exhibits54: Market opportunity by Product ($ million)
Exhibits55: Data Table on Market opportunity by Product ($ million)
Exhibits56: Chart on Distribution Channel – Market share 2022-2027 (%)
Exhibits57: Data Table on Distribution Channel – Market share 2022-2027 (%)
Exhibits58: Chart on Comparison by Distribution Channel
Exhibits59: Data Table on Comparison by Distribution Channel
Exhibits60: Chart on Offline – Market size and forecast 2022-2027 ($ million)
Exhibits61: Data Table on Offline – Market size and forecast 2022-2027 ($ million)
Exhibits62: Chart on Offline – Year-over-year growth 2022-2027 (%)
Exhibits63: Data Table on Offline – Year-over-year growth 2022-2027 (%)
Exhibits64: Chart on Online – Market size and forecast 2022-2027 ($ million)
Exhibits65: Data Table on Online – Market size and forecast 2022-2027 ($ million)
Exhibits66: Chart on Online – Year-over-year growth 2022-2027 (%)
Exhibits67: Data Table on Online – Year-over-year growth 2022-2027 (%)
Exhibits68: Market opportunity by Distribution Channel ($ million)
Exhibits69: Data Table on Market opportunity by Distribution Channel ($ million)
Exhibits70: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits71: Chart on Market share By Geographical Landscape 2022-2027 (%)
Exhibits72: Data Table on Market share By Geographical Landscape 2022-2027 (%)
Exhibits73: Chart on Geographic comparison
Exhibits74: Data Table on Geographic comparison
Exhibits75: Chart on North America – Market size and forecast 2022-2027 ($ million)
Exhibits76: Data Table on North America – Market size and forecast 2022-2027 ($ million)
Exhibits77: Chart on North America – Year-over-year growth 2022-2027 (%)
Exhibits78: Data Table on North America – Year-over-year growth 2022-2027 (%)
Exhibits79: Chart on Europe – Market size and forecast 2022-2027 ($ million)
Exhibits80: Data Table on Europe – Market size and forecast 2022-2027 ($ million)
Exhibits81: Chart on Europe – Year-over-year growth 2022-2027 (%)
Exhibits82: Data Table on Europe – Year-over-year growth 2022-2027 (%)
Exhibits83: Chart on Asia – Market size and forecast 2022-2027 ($ million)
Exhibits84: Data Table on Asia – Market size and forecast 2022-2027 ($ million)
Exhibits85: Chart on Asia – Year-over-year growth 2022-2027 (%)
Exhibits86: Data Table on Asia – Year-over-year growth 2022-2027 (%)
Exhibits87: Chart on Rest of World (ROW) – Market size and forecast 2022-2027 ($ million)
Exhibits88: Data Table on Rest of World (ROW) – Market size and forecast 2022-2027 ($ million)
Exhibits89: Chart on Rest of World (ROW) – Year-over-year growth 2022-2027 (%)
Exhibits90: Data Table on Rest of World (ROW) – Year-over-year growth 2022-2027 (%)
Exhibits91: Chart on US – Market size and forecast 2022-2027 ($ million)
Exhibits92: Data Table on US – Market size and forecast 2022-2027 ($ million)
Exhibits93: Chart on US – Year-over-year growth 2022-2027 (%)
Exhibits94: Data Table on US – Year-over-year growth 2022-2027 (%)
Exhibits95: Chart on China – Market size and forecast 2022-2027 ($ million)
Exhibits96: Data Table on China – Market size and forecast 2022-2027 ($ million)
Exhibits97: Chart on China – Year-over-year growth 2022-2027 (%)
Exhibits98: Data Table on China – Year-over-year growth 2022-2027 (%)
Exhibits99: Chart on Japan – Market size and forecast 2022-2027 ($ million)
Exhibits100: Data Table on Japan – Market size and forecast 2022-2027 ($ million)
Exhibits101: Chart on Japan – Year-over-year growth 2022-2027 (%)
Exhibits102: Data Table on Japan – Year-over-year growth 2022-2027 (%)
Exhibits103: Chart on Germany – Market size and forecast 2022-2027 ($ million)
Exhibits104: Data Table on Germany – Market size and forecast 2022-2027 ($ million)
Exhibits105: Chart on Germany – Year-over-year growth 2022-2027 (%)
Exhibits106: Data Table on Germany – Year-over-year growth 2022-2027 (%)
Exhibits107: Chart on France – Market size and forecast 2022-2027 ($ million)
Exhibits108: Data Table on France – Market size and forecast 2022-2027 ($ million)
Exhibits109: Chart on France – Year-over-year growth 2022-2027 (%)
Exhibits110: Data Table on France – Year-over-year growth 2022-2027 (%)
Exhibits111: Market opportunity By Geographical Landscape ($ million)
Exhibits112: Data Tables on Market opportunity By Geographical Landscape ($ million)
Exhibits113: Impact of drivers and challenges in 2022 and 2027
Exhibits114: Overview on Criticality of inputs and Factors of differentiation
Exhibits115: Overview on factors of disruption
Exhibits116: Impact of key risks on business
Exhibits117: Vendors covered
Exhibits118: Matrix on vendor position and classification
Exhibits119: Abbott Laboratories – Overview
Exhibits120: Abbott Laboratories – Business segments
Exhibits121: Abbott Laboratories – Key news
Exhibits122: Abbott Laboratories – Key offerings
Exhibits123: Abbott Laboratories – Segment focus
Exhibits124: AbbVie Inc. – Overview
Exhibits125: AbbVie Inc. – Product / Service
Exhibits126: AbbVie Inc. – Key news
Exhibits127: AbbVie Inc. – Key offerings
Exhibits128: Bausch Health Co. Inc. – Overview
Exhibits129: Bausch Health Co. Inc. – Business segments
Exhibits130: Bausch Health Co. Inc. – Key news
Exhibits131: Bausch Health Co. Inc. – Key offerings
Exhibits132: Bausch Health Co. Inc. – Segment focus
Exhibits133: Bayer AG – Overview
Exhibits134: Bayer AG – Business segments
Exhibits135: Bayer AG – Key news
Exhibits136: Bayer AG – Key offerings
Exhibits137: Bayer AG – Segment focus
Exhibits138: Boehringer Ingelheim International GmbH – Overview
Exhibits139: Boehringer Ingelheim International GmbH – Business segments
Exhibits140: Boehringer Ingelheim International GmbH – Key news
Exhibits141: Boehringer Ingelheim International GmbH – Key offerings
Exhibits142: Boehringer Ingelheim International GmbH – Segment focus
Exhibits143: Cipla Ltd. – Overview
Exhibits144: Cipla Ltd. – Business segments
Exhibits145: Cipla Ltd. – Key news
Exhibits146: Cipla Ltd. – Key offerings
Exhibits147: Cipla Ltd. – Segment focus
Exhibits148: Dr Reddys Laboratories Ltd. – Overview
Exhibits149: Dr Reddys Laboratories Ltd. – Business segments
Exhibits150: Dr Reddys Laboratories Ltd. – Key offerings
Exhibits151: Dr Reddys Laboratories Ltd. – Segment focus
Exhibits152: GlaxoSmithKline Plc – Overview
Exhibits153: GlaxoSmithKline Plc – Business segments
Exhibits154: GlaxoSmithKline Plc – Key news
Exhibits155: GlaxoSmithKline Plc – Key offerings
Exhibits156: GlaxoSmithKline Plc – Segment focus
Exhibits157: Haleon Plc – Overview
Exhibits158: Haleon Plc – Business segments
Exhibits159: Haleon Plc – Key offerings
Exhibits160: Haleon Plc – Segment focus
Exhibits161: Johnson and Johnson Services Inc. – Overview
Exhibits162: Johnson and Johnson Services Inc. – Business segments
Exhibits163: Johnson and Johnson Services Inc. – Key news
Exhibits164: Johnson and Johnson Services Inc. – Key offerings
Exhibits165: Johnson and Johnson Services Inc. – Segment focus
Exhibits166: Novartis AG – Overview
Exhibits167: Novartis AG – Business segments
Exhibits168: Novartis AG – Key offerings
Exhibits169: Novartis AG – Segment focus
Exhibits170: Pfizer Inc. – Overview
Exhibits171: Pfizer Inc. – Product / Service
Exhibits172: Pfizer Inc. – Key news
Exhibits173: Pfizer Inc. – Key offerings
Exhibits174: Prestige Consumer Healthcare Inc. – Overview
Exhibits175: Prestige Consumer Healthcare Inc. – Business segments
Exhibits176: Prestige Consumer Healthcare Inc. – Key offerings
Exhibits177: Prestige Consumer Healthcare Inc. – Segment focus
Exhibits178: Sanofi SA – Overview
Exhibits179: Sanofi SA – Business segments
Exhibits180: Sanofi SA – Key news
Exhibits181: Sanofi SA – Key offerings
Exhibits182: Sanofi SA – Segment focus
Exhibits183: Takeda Pharmaceutical Co. Ltd. – Overview
Exhibits184: Takeda Pharmaceutical Co. Ltd. – Product / Service
Exhibits185: Takeda Pharmaceutical Co. Ltd. – Key news
Exhibits186: Takeda Pharmaceutical Co. Ltd. – Key offerings
Exhibits187: Inclusions checklist
Exhibits188: Exclusions checklist
Exhibits189: Currency conversion rates for US$
Exhibits190: Research methodology
Exhibits191: Validation techniques employed for market sizing
Exhibits192: Information sources
Exhibits193: List of abbreviations



❖ 免責事項 ❖
http://www.globalresearch.jp/disclaimer

★リサーチレポート[ 世界の胃腸用OTC医薬品市場2023年-2027年(Global Gastrointestinal OTC Drugs Market 2023-2027)]についてメールでお問い合わせはこちらでお願いします。


◆H&Iグローバルリサーチのお客様(例)◆